US FDA grants orphan drug designation to AlveoGene’s novel, inhaled gene therapy, AVG-002 for lethal neonatal surfactant protein B deficiency: Oxford, UK Wednesday, December 4, ...

The American College of Medical Genetics and Genomics has just published its highly anticipated Evidence-Based Clinical ...

Are you eating wrong for your body? From caffeine to carbs, here's how genetic diets could be the revolutionary way to avoid ...

A study published in October 2024 in the journal Molecular Psychiatry found that brain volume changes correlate with social ...

SPR301 is a potential best-in-class gene therapy candidate that delivers a more stable, rationally engineered version of GCase, the enzyme ...

Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have been assigned an average recommendation of “Buy” ...

Sep. 9, 2024 — Researchers tested a preclinical model for an experimental gene therapy designed to treat multiple sulfatase deficiency (MSD), a disorder that affects the brain, lungs ...

The U.S. Food and Drug Administration has approved Kebilidi (eladocagene exuparvovec-tneq) for the treatment of adult and ...

A team of researchers from Adelaide, Australia, and the United States has uncovered a surprising connection between a rare ...

Is it true that chewing ice is bad for your teeth?Subscribe to The Post Most newsletter for the most important and ...

The study uncovers genetic factors driving early type 2 diabetes in South Asians, highlighting risks of insulin dependence and medication response challenges.